h1 IMF Videos From our weekly educational videos with leading myeloma experts to comprehensive news from key medical cancer conferences around the world, IMF videos are your all-access ticket to critical myeloma research, patient education, and guidance. TV Blog Categories All Content About the IMF ASCO/EHA ASH Ask Dr. Durie Black Swan Research Initiative Community Conversations Community Workshops Emerging Therapies Facebook Live Health Equity IMF History IMWG Inspirational Living Well with Myeloma M-POWER Myeloma in a Minute Myeloma Made Simple Myeloma University NLB Webcasts Patient & Family Webinar Q&A Recent News and Developments Treatments Trending Searches in Myeloma Search by text Per page 6122448 Sort Oldest firstNewest firstRelevanceA-ZZ-A ASH Jan 8, 2024 Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Eligible for ASCT: Primary Results of the Perseus Trial ASH Jan 8, 2024 Iberdomide Maintenance after Autologous Stem-Cell Transplantation in Newly Diagnosed MM: First Results of the Phase 2 EMN26 Study ASH Jan 8, 2024 Iceland’s iStopMM Study Revises Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance (MGUS) ASH Jan 8, 2024 The Phase 2 CARTITUDE-2 Trial: Updated Efficacy and Safety of Ciltacabtagene Autoleucel in Patients with Multiple Myeloma and 1–3 Prior Lines of Therapy (Cohort A) and with Early Relapse after First Line Treatment (Cohort B) ASH Jan 8, 2024 The STEM Trial Phase II Study on Cevostamab Consolidation After BCMA CAR T-Cell Therapy ASH Jan 8, 2024 Updates in Myeloma Treatment: BMS-986393 CAR T-Cell Therapy Shows Promise in Phase I Study for Relapsed/Refractory Patients Pagination First page « First Previous page ‹ Previous … Page 37 Current page 38 Page 39 Page 40 … Next page Next › Last page Last »
